RefleXion

Hayward, United States Founded: 2009 • Age: 17 yrs
Biology-guided radiotherapy systems are provided for cancer treatment.

About RefleXion

RefleXion is a Healthcare company based in Hayward (United States) founded in 2009 by Samuel Mazin. Biology-guided radiotherapy systems are provided for cancer treatment. RefleXion has raised $553.91 million across 18 funding rounds from investors including Pfizer, Johnson & Johnson and T. Rowe Price. Its chief executive, as recorded, is Todd Powell. Its website reflexion.com draws about 11 thousand monthly visits. RefleXion offers products and services including SCINTIX Therapy and RefleXion X1. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies. Its legal entity is REFLEXION MEDICAL. Its competitors include Mevion Medical Systems, ZAP-X and Nanospectra; 3 of its 3 listed competitors have raised funding.

Company details

RefleXion was founded in 2009 and is headquartered in Hayward, United States. The company operates in the medical technology sector, focusing on radiotherapy solutions. Its technology integrates Positron Emission Tomography to enable real-time tumor tracking and personalized radiation delivery. Applications target lung, prostate, and breast cancers, supporting precise treatment processes in oncology care.

Operational Areas
Key Metrics
  • Total Equity Funding
    $553.91M (USD)

    in 18 rounds

  • Latest Funding Round
    $106.71M (USD), Series F

    Nov 2023

  • Investors
    Pfizer

    & 20 more

Products & Services of RefleXion

RefleXion offers a comprehensive portfolio of products and services, including SCINTIX Therapy and RefleXion X1.

SCINTIX Therapy
Radiotherapy Platform

Utilizes cancer emissions for real-time tumor tracking and treatment.

RefleXion X1
Medical Device

Combines PET imaging with radiotherapy to target moving tumors.

Apps and channels of RefleXion

its YouTube channel RefleXion Medical has 352 subscribers and 23 videos.

RefleXion Medical
YouTube 352 subscribers 23 videos Science & Technology
Open channel

Videos from RefleXion

The most watched videos on RefleXion's YouTube channel, RefleXion Medical (352 subscribers). Click a video to play it here.

Tumors Don’t Sit Still During Radiation Therapy
214.2K views
SCINTIX Biology-guided Radiotherapy for Metastatic Disease
144.7K views
Cancer Just Met Its Match
77.2K views
SCINTIX biology-guided radiotherapy
61.3K views

More on RefleXion Medical.

Funding Insights of RefleXion

RefleXion has successfully raised a total of $553.91M across 18 strategic funding rounds. The most recent funding activity was a Series F round of $106.71 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $553.91M
  • Total Rounds 18
  • Last Round Series F β€” $106.71M
  • First Round $1.5M

    (Jul 2010)

  • Investors Count 21

Latest 10 of 18 funding rounds of RefleXion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2023$106.71MSeries F–The Rise Fund
Jul 2022$125MDebt – Conventional––
Mar 2022$80MSeries E–Ascension, Catalio Capital Management
Mar 2021$40MSeries D––
Apr 2020$100MSeries D–PSP Investments
May 2019$60MDebt – Conventional––
Apr 2018$2.3MGrant––
Mar 2018$100MSeries C–The Rise Fund
Jul 2016$52MSeries B––
–
Apr 2016$52MSeries B–KCK MedTech
Valuation history

21 investors in total: 21 institutional.

Investors in RefleXion

RefleXion has secured backing from 21 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Johnson & Johnson and T. Rowe Price.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Sector-agnostic VC investment company investing globally
therisefund.comSan Francisco, United States
Private equity and hedge fund investments in healthcare are managed.
ally-bridge.comHong Kong, China
Venture capital firm focused on tech sectors
venrock.comPalo Alto, United States
Venture capital is provided to biomedical technology startups.
cataliocapital.comNew York, United States
Venture debt firm focused on the life sciences sector
2002oxfordfinance.comAlexandria, United States
Ascension is recognized as a venture capital firm focused on early-stage tech investments.
ascension.vcLondon, United Kingdom
Venture capital fund focused on tech startups
sixtydegreecapital.comNorth York, Canada
Venture capital firm backed by Johnson & Johnson
jnjinnovation.com/jjdcCambridge, United States
Sofinnova Partners is focused on life sciences and healthcare investments.
sofinnovapartners.comParis, France
Premium access

Investor details for RefleXion

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of RefleXion

68 people are tracked at RefleXion (30 in leadership, 18 in board & advisors, 20 in team).

NameRoleGroup
Samuel Mazin
Co-Founder & CTOLeadership
Todd Powell
CEO & PresidentLeadership
Shiyu Xu
Senior Managing Principal Algorithm EnginerLeadership
Judy Bartlett-Roberto
VP, MarketingLeadership
Atul Nayak
Sr. Director, External Innovation - Strategy & OperationsLeadership
Jeff Holifield
Vice President & Head of LegalLeadership
Leonard Lyons
VP, SalesLeadership
Philip J. Aulson II
Senior Vice President of Operations and ServiceLeadership
Sukh Sandher
Sr. Director Of Quality EngineeringLeadership
Shervin 'Sean' Shirvani
CMOLeadership
Aaron Sass
Director Of SalesLeadership
Jermaine Cuyler
Director Of Sales - East CoastLeadership
Elise Govek Sphr, Phr-Ca
Human Resources DirectorLeadership
Karine A. al Feghali M.D., Msc
Senior Medical Director, Medical AffairsLeadership
Jay Janardhanan
Vice President Software EngineeringLeadership
James Zug
Director Of Software ApplicationsLeadership
Hector Ruiz de Vinaspre
Director Of SalesLeadership
Arjun Maniyedath
Vice President, Scientific & Medical ProgramsLeadership
Sean Shirvani M.D. Mph
Chief Medical OfficerLeadership
Jason McCurry
Chief Information Security Officer, Senior Director Of ITLeadership

48 more people are available in the full profile.

Premium access

Complete people profiles for RefleXion

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of RefleXion

3 dated milestones of RefleXion across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded RefleXion is founded.
  2. Funding First funding round of $1.5M.
  3. Funding Latest funding round, Series F, of $106.7M.

Competitors of RefleXion

RefleXion has 3 listed competitors in our database, 3 of them funded. They include Mevion Medical Systems, ZAP-X and Nanospectra.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
mevion.com2004Littleton, United States$500.18M136
Proton therapy systems are supplied for cancer radiation treatment.
zapsurgical.com2014San Carlos, United States$159M
Developer of gyroscopic radiosurgery platform
nanospectra.com2002Houston, United States$24.52M9
Nanoparticle-based therapies for solid tumor treatment are developed.
Premium access

Detailed competitors of RefleXion

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of RefleXion

The website of RefleXion (reflexion.com) receives about 10.8K visits a month.

  • Monthly visits
    10.8K

    ▲ 12.1% vs previous month

Top companies in Oncology

3 companies that operate in the same segment as RefleXion (Oncology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Reflexion

Premium access

Complete news archive for RefleXion

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about RefleXion

RefleXion was founded in 2009 and raised its 1st funding round 1 year after it was founded.

RefleXion is headquartered in Hayward, United States. It is registered at Hayward, California, United States.

Todd Powell is the CEO of RefleXion, as recorded in our data.

RefleXion is a funded company, having raised a total of $553.91M across 18 funding rounds to date. The company's 1st funding round was a Series B of $52M, raised on Jul 2010.

RefleXion was founded in 2009 and is headquartered in Hayward, United States. The company operates in the medical technology sector, focusing on radiotherapy solutions. Its technology integrates Positron Emission Tomography to enable real-time tumor tracking and personalized radiation delivery. Applications target lung, prostate, and breast cancers, supporting precise treatment processes in oncology care.

RefleXion's top competitors include ZAP-X, Mevion Medical Systems and Nanospectra.

RefleXion offers SCINTIX Therapy and RefleXion X1.

RefleXion has 21 investors. Key investors include Pfizer, Johnson & Johnson, T. Rowe Price, HHS, and Hillenbrand.

RefleXion operates through Reflexion Medical.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available